Clinical Trials
12 trialsNCT03406299 2026-04-09
Phase II Randomized Trial of SLOG vs GC in Locally Advanced or Metastatic Biliary Tract Cancer
National Health Research Institutes, Taiwan
Phase 2 Completed
NCT05223088 2025-03-18
Tislelizumab Combined With Apatinib and Oxaliplatin Plus S1 as Neoadjuvant Therapy for Borrmann IV、Large Borrmann III Type and Bulky N Positive Advanced Gastric Cancer
Fujian Cancer Hospital
Phase 2 Completed
NCT00004860 2023-06-15
Fluorouracil-Uracil and Leucovorin in Treating Elderly Patients With Metastatic Colorectal Cancer
Eastern Cooperative Oncology Group
Phase 2 Completed
NCT03415802 2021-02-01
Efficacy and Safety of Nab-Paclitaxel Plus S-1 in the First-line Treatment of Advanced Pancreatic Cancer
ChineseAMS
Phase 2 Completed
NCT02527785 2017-08-23
Study of Oxaliplatin, Irinotecan, and S-1 in Gastric Cancer
Hallym University Medical Center
Phase 2 Completed
NCT02447679 2017-02-07
Oral Thalidomide and Tegafur-uracil to Decrease Hepatocellular Carcinoma Recurrence
Chang Gung Memorial Hospital
Phase 2 Completed
NCT02903498 2016-10-12
The Maintenance Treatment of UFT in Advanced Gastric Cancer
Fudan University
Phase 2 Completed
NCT01225744 2014-06-11
eSCOUT
The Christie NHS Foundation Trust
Phase 2 Completed
NCT02090153 2014-03-18
Study of S-1 Plus LV for Advanced Gastric Cancer
Sun Yat-sen University
Phase 2 Completed
NCT00519688 2011-10-17
UFUR Plus Thalidomide for Advanced Hepatocellular Carcinoma
National Taiwan University Hospital
Phase 2 Completed
NCT01037998 2009-12-23
UFUR (Tegafur/Uracil) Plus Iressa in Non-small-cell Lung Cancer
Taipei Veterans General Hospital, Taiwan
Phase 2 Completed
NCT00464919 2009-07-07
Sorafenib Plus Tegafur/Uracil (UFUR®) for Hepatocellular Carcinoma (HCC)
National Taiwan University Hospital
Phase 2 Completed